
CREB1ãæ ¢æ§ç¡ç äžè¶³ãšäžå®ã®ååãªã³ã¯ãšããŠæµ®äž
CREB1ãæ ¢æ§ç¡ç äžè¶³ãšäžå®ã®ååãªã³ã¯ãšããŠæµ®äž CREB1éºäŒåã®çºçŸãé«ããéºäŒåå€ç°ãæã€äººã¯ãäžå®é害ãçºçãããªã¹ã¯ã28%é«ãããšãã3ã€ã®ç¬ç«ãã蚌æ 系統ãäžè§æž¬éããæ°ããªç ç©¶ã§æããã«ãªã£ãããã®çºèŠã¯ãProgress in Neuro-Psychopharmacology & Biological Psychiatryã«æ²èŒãããCREB1ãæ ¢æ§ç¡ç äžè¶³ãšç çãªäžå®ãçµã¶äžå¿çãªååæ¶ãæ©ãšããŠäœçœ®ã¥ããŠãããççããã®äžéå åã§ããå¯èœæ§ãé«ãã ãã©ã³ã¹ã¯ãªãããŒã ã¹ã¯ãªãŒãã³ã° äžåœã®æµ·åå»ç§å€§åŠã®Zhujiang Baiçããç ç©¶ããŒã ã¯ããŸãäžç çæ£è ãšäžå®é害æ£è ã®å ¬ééºäŒåçºçŸããŒã¿ã»ãããåè§£æããããšããå§ãããäž¡æ¹ã®ç¶æ ã§èª¿ç¯ãä¹±ããŠããéºäŒåãæ¢çŽ¢ããå ±éã®ååã·ã°ããã£ãŒãå ±éã®çç©åŠççµè·¯ãæããã«ããå¯èœæ§ããããšæšè«ããã ã¹ã¯ãªãŒãã³ã°ã«ãããäžç çãšäžå®çã«å ±éãã37ã®å·®æ¬¡ççºçŸéºäŒåãåŸããããããŒã ããã®ã»ããã§ãšã³ãªããã¡ã³ãè§£æãå®è¡ãããšãããã·ã°ãã«ã¯æçœã ã£ããéºäŒåã¯å§åçã«ççé¢é£ã®çç©åŠçããã»ã¹ã«æ¿çž®ãããŠããããã®èšç®ã«ããçºèŠã¯ãããŒã ãå®éšå®€ã§ãã®é¢é£æ§ãæ€èšŒããããã®æºåãæŽããã å®éšã¢ãã« å æé¢ä¿ãæ¢ããããç ç©¶è ãã¯æ ¢æ§ç¡ç äžè¶³ã®ã©ããã¢ãã«ãçšãããé·æã«ãããç¡ç äžè¶³ã«ãããããã©ããã¯ãææãšæ ååŠçã®äžæ¢ã§ããè³é åã§ããææ¡äœã«ãããŠãè «ç壿»å åã¢ã«ãã¡ïŒTNF-αïŒãã€ã³ã¿ãŒãã€ãã³-6ïŒIL-6ïŒãªã©ã®ççããŒã«ãŒã®é¡èãªå¢å ã瀺ããã Iba1çºçŸã§æž¬å®ããããã¯ãã°ãªã¢æŽ»æ§åãäžæããŠãããäžè¬çãªçç以å€ã«ããããŒã ã¯ç¹å®ã®ã·ã°ãã«äŒéã¿ã³ãã¯è³ªã远跡ããããªã³é žåNF-κB p65ããªã³é žåERK1/2ããªã³é žåCREB1ã®ã¬ãã«ã¯ãã¹ãŠãç¡ç äžè¶³ã®åç©ã®ææ¡äœã§ææã«å¢å ããŠãããç·CREB1ã¿ã³ãã¯è³ªã¯å€åããŠããããç¡ç äžè¶³ãCREB1ã®å šäœçãªéã®å€åã§ã¯ãªããç¿»èš³åŸæŽ»æ§åãä¿é²ããããšã瀺ããŠããã ããŒã ã¯ãŸããè³ç±æ¥ç¥çµæ é€å åïŒBDNFïŒãšã±ã¢ã«ã€ã³å容äœCXCR4ã®å¢å ã芳å¯ããCXCR4ã¯ç¡ç äžè¶³ãšCREB1掻æ§åãçµã³ã€ããäžæµã®ç¥çµå ç«åè£ãšããŠç¹å®ããããCXCR4ã¯ããŒã¿ã®å¶éã«ãããç ç©¶ã®ããéºäŒåŠçéšåã§ã¯ãã以äžãã¹ãã§ããªãã£ãã éºäŒåŠçèšŒæ æãé¡èãªèšŒæ ã¯ãã¡ã³ãã«ã©ã³ãã åããåŸããããããã¯ãèªç¶ã«ååšããéºäŒåå€ç°ãæäœå€æ°ãšããŠäœ¿çšããŠå æå¹æãæšå®ããéºäŒç«åŠçææ³ã§ãããããŒã ã¯eQTLGenã³ã³ãœãŒã·ã¢ã ã®CREB1ã®çºçŸéç圢質éºäŒå座ïŒeQTLïŒãšããã£ã³ã©ã³ãã®å€§èŠæš¡ãã€ãªãã³ã¯FinnGenã®ã¢ãŠãã«ã ããŒã¿ã䜿çšããã éºäŒçã«äºæž¬ãããCREB1çºçŸã®äžæã¯ãäžå®ãªã¹ã¯ã®28%å¢å ãšé¢é£ããŠããïŒãªããºæ¯1.28ã95%ä¿¡é Œåºé1.06ïœ1.54ãp = 0.0089ïŒãéºäŒçå€ç°ã¯åèæã«åºå®ãããçæŽ»ç¿æ £ãç°å¢èŠå ã«ãã£ãŠå®¹æã«äº€çµ¡ãããªããããã¡ã³ãã«ã©ã³ãã åã¯èгå¯ç ç©¶ã®ã¿ãããå æé¢ä¿ã«é¢ãããã匷åãªèšŒæ ãæäŸããã éèŠæ§ æ ¢æ§ç¡ç äžè¶³ã¯äžçäžã®æäººã®çŽ3åã®1ã«åœ±é¿ãåãŒããŠãããäžççã«æãäžè¬çãªç²Ÿç¥å¥åº·ç¶æ ã§ããäžå®é害ã®ç¢ºç«ãããå±éºå åã§ãããããããç¡ç äžè¶³ãšäžå®ã®å¢å€§ãçµã³ã€ããååã¡ã«ããºã ã¯ããããŸã§ååã«çè§£ãããŠããªãã£ãã ãã©ã³ã¹ã¯ãªãããŒã ãå®éšãéºäŒåŠç蚌æ ã®CREB1ãžã®åæã¯ãã¡ã«ããºã ã®èª¬æãæäŸããããã®ã¿ã³ãã¯è³ªã¯è»¢åå åã§ãããç¥çµå¯å¡æ§ãã¹ãã¬ã¹å¿çãççã«é¢äžããéºäŒåã®çºçŸã調ç¯ãããæ¬ç ç©¶ã¯ãæ ¢æ§ç¡ç äžè¶³ãCXCR4ãNF-κBã·ã°ãã«äŒéãERKãªã³é žåãäŒŽãææ¡äœã®ç¥çµå ç«ã«ã¹ã±ãŒããåŒãèµ·ãããæçµçã«CREB1掻æ§åãšäžå®ãä¿é²ããäžæµã®å€åãããããããšã瀺åããŠããã 確èªãããã°ããããã®ç¥èŠã¯æ°èŠã®æ²»çæšçã瀺åããå¯èœæ§ããããCREB1掻æ§ã調ç¯ããããäžæµã®ççã«ã¹ã±ãŒããäžæãããããè¬å€ã¯ããã€ãç¡ç é害ã«èµ·å ããäžå®ãæã€æ£è ã«æ°ããªéžæè¢ãæäŸãããããããªãã éç ã¡ã³ãã«ã©ã³ãã åã¯å æé¢ä¿ã瀺åããããšã¯ã§ããŠããååã¬ãã«ã§èšŒæããããšã¯ã§ããªããeQTLããŒã¿ã¯è³çµç¹ã§ã¯ãªãè¡æ¶²äžã®CREB1çºçŸãåæ ããŠãããFinnGenã³ããŒãã¯äž»ã«ãšãŒãããç³»ã§ãããäžè¬åå¯èœæ§ãå¶éããããCXCR4仮説ã¯çç©åŠçã« plausibility ããããã®ã®ãããéºäŒåããŒã¿ã§ãã¹ãã§ããããã£æ¯é¡å®éšã«ãã£ãŠã®ã¿æ¯æãããŠããã远å ã®ã³ããŒãã§ã®åçŸãšçŽæ¥çãªè³çµç¹ç ç©¶ãå¿ èŠã§ããã çµè« 3ã€ã®åæãã蚌æ 系統ã¯ãæ ¢æ§ç¡ç äžè¶³ãšäžå®ã®éã®ååãªã³ã¯ãšããŠCREB1掻æ§åãæã瀺ããŠãããççãéèŠãªã¡ãã£ãšãŒã¿ãŒãšãªã£ãŠããããã®çºèŠã¯ãç¡ç äžè¶³ãã©ã®ããã«è³åè·¯ãå圢æããããçè§£ããæ°ããªéãéãããã®çµè·¯ãæ²»ççã«æšçãšããå¯èœæ§ãæèµ·ããã ãœãŒã¹ Bai Z, Ye W, Chen Z, Shen W, Sun Z. CREB1 mediates chronic sleep deprivation-induced anxiety via neuroimmune mechanisms. Progress in Neuro-Psychopharmacology & [âŠ]










